Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

National Cholesterol Education Program Adult Treatment Panel III

Grundy SM, Cleeman JT, Merz CN et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 227-239... [Pg.700]

Statins (and National Cholesterol Education Program Adult Treatment Panel III diet)... [Pg.27]

The National Cholesterol Education Program Adult Treatment Panel III guidelines have set the optimal level for low-density lipoprotein (LDL) cholesterol for all adults as less than 100 mg/dL (2.59 mmol/L). [Pg.175]

Insulin resistance has been associated with a number of other cardiovascular risks, including abdominal obesity, hypertension, dyslipidemia, hypercoagulation, and hyperinsulinemia. The clustering of these risk factors has been termed metabolic syndrome. It is estimated that 50% of the United States population older than 60 years of age have metabolic syndrome. The most widely used criteria to define metabolic syndrome were established by the National Cholesterol Education Program Adult Treatment Panel III Guidelines (summarized in Table 40-2). [Pg.646]

The National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) recommends that a fasting lipoprotein profile and risk factor assessment be used in the initial classification of adults. [Pg.113]

Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update adjustments and options. Am J Cardiol. 2005 96(4A) 53E-59E. [Pg.366]

Feldman T, Koren M, Insull W, et al. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals. Am.J. Cardiol, 2004, 93, 1481-1486. [Pg.156]

S. M. Grundy, J. I. Cleeman, C. N. Merz, H. B. Brewer, Jr., L. T. Clark, D. B. Hunninghake, R. C. Pasternak, S. C. Smith, Jr., and N. J. Stone, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vase Biol 24 el49-el61 (2004). [Pg.895]


See other pages where National Cholesterol Education Program Adult Treatment Panel III is mentioned: [Pg.193]    [Pg.662]    [Pg.238]    [Pg.150]    [Pg.1020]    [Pg.286]    [Pg.7]    [Pg.33]   
See also in sourсe #XX -- [ Pg.100 , Pg.225 ]

See also in sourсe #XX -- [ Pg.100 , Pg.225 ]




SEARCH



Adults

National Cholesterol Education Program

National Cholesterol Education Program Adult Treatment Panel

Treatment programs

© 2024 chempedia.info